Raymond James Financial’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Sell
63,271
-95
-0.1% -$1.89K ﹤0.01% 3842
2026
Q1
$1.22M Buy
63,366
+1,794
+3% +$35.3K ﹤0.01% 3722
2025
Q4
$1.17M Buy
61,572
+2,765
+5% +$51.2K ﹤0.01% 3680
2025
Q3
$1.1M Buy
58,807
+13,903
+31% +$260K ﹤0.01% 3619
2025
Q2
$828K Buy
44,904
+138
+0.3% +$2.45K ﹤0.01% 3693
2025
Q1
$782K Sell
44,766
-6,471
-13% -$109K ﹤0.01% 3658
2024
Q4
$887K Buy
+51,237
New +$936K ﹤0.01% 3532

Other funds holding SBRA

Raymond James Financial's SBRA Position: Q2 2026 in Review

Raymond James Financial reduced its Sabra Healthcare REIT (SBRA) stake by 0.15% in Q2 2026, selling an estimated $1.89K and leaving 63,271 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #3842.

Raymond James Financial first reported a position in SBRA in Q4 2024 and has held it in 7 quarters since. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Raymond James Financial held 63,271 shares of Sabra Healthcare REIT worth $1.23M as of Q2 2026.
  • Raymond James Financial sold 95 Sabra Healthcare REIT shares in Q2 2026, an estimated $1.89K.
  • Sabra Healthcare REIT made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3842 holding.
  • Raymond James Financial first reported a position in Sabra Healthcare REIT in Q4 2024 and has held it in 7 quarters since.
  • 466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.